Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November

Drug giant Pfizer said it could be ready to apply for emergency-use authorization of its Covid-19 vaccine by late November, assuming it receives positive efficacy and safety data from late-stage human trials.

Read the full article here

Related Articles